Ovid Therapeutics Inc.
OVID
$1.55
-$0.01-0.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.19% | -154.98% | 12.48% | 39.61% | -24.48% |
| Total Depreciation and Amortization | -90.53% | -33.11% | 3.68% | 14.29% | 15.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.13% | 103.89% | 132.97% | 83.81% | -43.90% |
| Change in Net Operating Assets | 3.09% | -129.70% | 25.11% | -123.34% | -6,117.24% |
| Cash from Operations | 14.23% | 66.51% | 38.39% | 15.98% | -49.29% |
| Capital Expenditure | -- | -- | -- | -69.23% | 166.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,654.51% | -6.25% | -74.75% | 143.94% | 106.61% |
| Cash from Investing | 1,630.48% | -6.00% | -74.73% | 143.89% | 106.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -60.53% | -100.00% | -94.30% | -100.00% | -83.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.53% | -100.00% | -94.30% | -100.00% | -83.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 46.83% | 775.23% | -238.43% | 137.13% | -3.45% |